Chiral nanophotonic materials are promising candidates for biosensing applications because they focus light into nanometer dimensions, increasing their sensitivity to the molecular signatures of their surroundings. Recent advances in nanomaterial-enhanced chirality sensing provide detection limits as low as attomolar concentrations (10^–18 M) for biomolecules and are relevant to the pharmaceutical industry, forensic drug testing, and medical applications that require high sensitivity. Here, we review the development of chiral nanomaterials and their application for detecting biomolecules, supramolecular structures, and other environmental stimuli. We discuss superchiral near-field generation in both dielectric and plasmonic metamaterials that are composed of chiral or achiral nanostructure arrays. These materials are also applicable for enhancing chiroptical signals from biomolecules. We review the plasmon-coupled circular dichroism mechanism observed for plasmonic nanoparticles and discuss how hotspot-enhanced plasmon-coupled circular dichroism applies to biosensing. We then review single-particle spectroscopic methods for achieving the ultimate goal of single-molecule chirality sensing. Finally, we discuss future outlooks of nanophotonic chiral systems.

Probing protein-nanorod aggregates: The interaction of proteins with nanoparticles can enhance circular dichroism signals and provide a route for sensitive biodetection. However, ensemble measurements are insufficient for resolving the origin of plasmon-coupled circular dichroism (PCCD). Zhang et al. used single-particle circular differential scattering spectroscopy along with correlated tomographic reconstruction and electromagnetic simulations to study individual aggregates of bovine serum albumin and gold nanorods (see the Perspective by Kim and Kotov). Aggregates contribute to PCCD activity through formation of plasmonic hotspots, but single nanoparticles do not contribute. The protein does not function simply as a chiral chromophore but enables assembly of the chiral nanorod-protein complexes. Science , this issue p. 1475 ; see also p. 1378